190 related articles for article (PubMed ID: 37873031)
1. An Activity-Based Nanosensor for Minimally-Invasive Measurement of Protease Activity in Traumatic Brain Injury.
Kudryashev JA; Madias MI; Kandell RM; Lin QX; Kwon EJ
Adv Funct Mater; 2023 Jul; 33(28):. PubMed ID: 37873031
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Extracellular Matrix in Traumatic Brain Injury Increases Signal Generation from an Activity-Based Nanosensor.
Kandell RM; Kudryashev JA; Kwon EJ
ACS Nano; 2021 Dec; 15(12):20504-20516. PubMed ID: 34870408
[TBL] [Abstract][Full Text] [Related]
3. An Activity-Based Nanosensor for Traumatic Brain Injury.
Kudryashev JA; Waggoner LE; Leng HT; Mininni NH; Kwon EJ
ACS Sens; 2020 Mar; 5(3):686-692. PubMed ID: 32100994
[TBL] [Abstract][Full Text] [Related]
4. A literature review of the feasibility of glial fibrillary acidic protein as a biomarker for stroke and traumatic brain injury.
Schiff L; Hadker N; Weiser S; Rausch C
Mol Diagn Ther; 2012 Apr; 16(2):79-92. PubMed ID: 22497529
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study.
Korley FK; Jain S; Sun X; Puccio AM; Yue JK; Gardner RC; Wang KKW; Okonkwo DO; Yuh EL; Mukherjee P; Nelson LD; Taylor SR; Markowitz AJ; Diaz-Arrastia R; Manley GT;
Lancet Neurol; 2022 Sep; 21(9):803-813. PubMed ID: 35963263
[TBL] [Abstract][Full Text] [Related]
6. Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice.
Thompson SN; Gibson TR; Thompson BM; Deng Y; Hall ED
Exp Neurol; 2006 Sep; 201(1):253-65. PubMed ID: 16814284
[TBL] [Abstract][Full Text] [Related]
7. Penetrating Traumatic Brain Injury Triggers Dysregulation of Cathepsin B Protein Levels Independent of Cysteine Protease Activity in Brain and Cerebral Spinal Fluid.
Boutté AM; Hook V; Thangavelu B; Sarkis GA; Abbatiello BN; Hook G; Jacobsen JS; Robertson CS; Gilsdorf J; Yang Z; Wang KKW; Shear DA
J Neurotrauma; 2020 Jul; 37(13):1574-1586. PubMed ID: 31973644
[TBL] [Abstract][Full Text] [Related]
8. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
[TBL] [Abstract][Full Text] [Related]
9. GFAP-BDP as an acute diagnostic marker in traumatic brain injury: results from the prospective transforming research and clinical knowledge in traumatic brain injury study.
Okonkwo DO; Yue JK; Puccio AM; Panczykowski DM; Inoue T; McMahon PJ; Sorani MD; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Manley GT;
J Neurotrauma; 2013 Sep; 30(17):1490-7. PubMed ID: 23489259
[TBL] [Abstract][Full Text] [Related]
10. Association between Blood and Computed Tomographic Imaging Biomarkers in a Cohort of Mild Traumatic Brain Injury Patients.
Chen H; Ding VY; Zhu G; Jiang B; Li Y; Boothroyd D; Rezaii PG; Bet AM; Paulino AD; Weber A; Glushakova OY; Hayes RL; Wintermark M
J Neurotrauma; 2022 Oct; 39(19-20):1329-1338. PubMed ID: 35546284
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats.
Pike BR; Flint J; Dutta S; Johnson E; Wang KK; Hayes RL
J Neurochem; 2001 Sep; 78(6):1297-306. PubMed ID: 11579138
[TBL] [Abstract][Full Text] [Related]
12. The Role of Blood Biomarkers for Magnetic Resonance Imaging Diagnosis of Traumatic Brain Injury.
Yue JK; Upadhyayula PS; Avalos LN; Deng H; Wang KKW
Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32098419
[No Abstract] [Full Text] [Related]
13. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.
Gatson JW; Barillas J; Hynan LS; Diaz-Arrastia R; Wolf SE; Minei JP
J Neurosurg; 2014 Nov; 121(5):1232-8. PubMed ID: 25192482
[TBL] [Abstract][Full Text] [Related]
14. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.
Diaz-Arrastia R; Wang KK; Papa L; Sorani MD; Yue JK; Puccio AM; McMahon PJ; Inoue T; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Okonkwo DO; Manley GT;
J Neurotrauma; 2014 Jan; 31(1):19-25. PubMed ID: 23865516
[TBL] [Abstract][Full Text] [Related]
15. Nanoporous Carbon Immunosensor for Highly Accurate and Sensitive Clinical Detection of Glial Fibrillary Acidic Protein in Traumatic Brain Injury, Stroke, and Spinal Cord Injury.
Khetani S; Salahandish R; Tabor JB; Chilvers M; Dukelow S; Ho C; Campbell C; Sen A; Debert CT; Sanati-Nezhad A
ACS Biomater Sci Eng; 2023 Jun; 9(6):3556-3569. PubMed ID: 37067234
[TBL] [Abstract][Full Text] [Related]
16. Development of a novel, sensitive translational immunoassay to detect plasma glial fibrillary acidic protein (GFAP) after murine traumatic brain injury.
Button EB; Cheng WH; Barron C; Cheung H; Bashir A; Cooper J; Gill J; Stukas S; Baron DC; Robert J; Rowe EM; Cripton PA; Wellington CL
Alzheimers Res Ther; 2021 Mar; 13(1):58. PubMed ID: 33678186
[TBL] [Abstract][Full Text] [Related]
17. Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI.
Shahim P; Politis A; van der Merwe A; Moore B; Ekanayake V; Lippa SM; Chou YY; Pham DL; Butman JA; Diaz-Arrastia R; Zetterberg H; Blennow K; Gill JM; Brody DL; Chan L
Neurology; 2020 Aug; 95(6):e623-e636. PubMed ID: 32641529
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
